Today's News | Note: News feeds may no longer be available for the articles on this page.

Obama Plan to Copy Biotech Drugs May Get Early Push by Momenta 5:02 AM 3/10/2009
Bloomberg - USA
Momenta Pharmaceuticals Inc would like to be the first drugmaker to win US FDA clearance to sell generic versions of a biotechnology-based drug. So would Teva, Sandoz, and many others, but the hurdle is still too high. ...

FDA to meet to review Genentech drug for new use 4:19 PM 3/9/2009
Forbes - NY,USA
The US FDA will review Genentech's blockbuster cancer drug Avastin for a new use in patients with glioblastoma multiforme which is the deadliest type of brain tumor. ...

Evotec Shares Surge on Drug Rights Sale to Roche 10:05 AM 3/9/2009
Bloomberg - USA
Evotec AG sells the rights to an experimental depression drug to Roche Holding AG. ...

Human Genome's hepatitis C drug meets main goal 7:26 AM 3/9/2009
Reuters - USA
Human Genome Sciences' drug albuferon to treat chronic hepatitis C met the main goal in a second late-stage trial. The company expects to file for marketing approvals this fall. ...

Merck to buy Schering-Plough for $41.1 billion 6:18 AM 3/9/2009
MarketWatch - USA
Pharmaceutical giant Merck & Co will buy rival Schering-Plough for $41.1 billion to bolster its pipeline of potential new drugs and expand in emerging markets. ...

Takeda shares slammed by drug delay worries 3:55 AM 3/9/2009
Reuters - USA
Shares of Takeda Pharmaceutical dived 13 percent on fears the replacement for its best-selling diabetes drug could be delayed by years in the US. ...

Watson to pay $18 mln to Elan in settlement 5:04 PM 3/7/2009
BusinessWeek - USA
Watson Pharmaceuticals Inc will pay $18 million to Elan Corp to settle a patent lawsuit over Watson's generic version of pain reliever Naprelan (naproxen sodium) tablets. ...

New Life For Stem-Cell Funding Boosts Biotech 12:28 PM 3/7/2009
Forbes - NY,USA
Shares of Geron, StemCells Inc, and Cytori Therapeutics soared on word that President Obama will lift the limit on embryonic stem-cell research funding. ...

Oceans Could Hold Potential for New Drugs 2:29 PM 3/7/2009
MSNBC - USA
The oceans are an untapped treasure trove of life-saving drugs. ...

Roche Raises Bid for Genentech to $93 a Share 7:06 AM 3/7/2009
New York Times - United States
Roche raised the price to buy out Genentech from $86.50 to $93. Genentech thinks the company is worth $112 a share. ...

Markets bet on Roche clinching Genentech deal 12:51 PM 3/6/2009
Reuters - USA
Investors in Roche Holding AG are growing confident it will succeed in buying out Genentech Inc after the Swiss drugmaker raised more funds than it needs to finance its current offer. ...

Forest, Cypress delay launch of fibromyalgia drug 10:03 AM 3/6/2009
Reuters - USA
Forest and Cypress have US FDA approval to market Savella for fibromyalgia, but have to push the ship date back to mid-2009 to make a formulation change. ...

Almirall, Forest delay lung drug NDA submission 5:39 AM 3/6/2009
Reuters - USA
Spain's Almirall could delay a new drug application for its lung treatment aclidinium bromide in the US following a meeting with the FDA. Additional clinical studies will be needed for the treatment of Chronic Obstructive Pulmonary Disease. ...

Takeda: US needs more data to OK diabetes drug 5:09 AM 3/6/2009
Reuters - USA
Takeda Pharmaceutical said the US FDA wants more clinical data to complete a review of key diabetes drug candidate SYR-322 (alogliptin). It's expected to replace best-selling Actos which loses patent protection in 2011. ...

Pfizer and Sanofi eye Wockhardt's biotech unit: report 4:32 AM 3/6/2009
Reuters - USA
Pfizer Inc and Sanofi-Aventis may be competing for a stake in Indian Wockhardt Ltd's biotechnology business. ...

<- Day Earlier | Today's News